Quick Menu

Human - Anti-Bacterial and Dietary Protein Antibody Assay

All Human Anti-Bacterial and Dietary Protein Antibody Assays are currently on backorder. We apologize for any inconvenience this may cause.

Environmental factors, especially intestinal microbes and their toxins, may contribute to the development of autoimmune diseases such as rheumatoid arthritis (RA) (1-7), inflammatory bowel diseases (IBDs) (8, 9), systemic lupus erythematosis (SLE) (10) and other chronic disorders (11-14).   Moreover, the translocation of live bacteria, their cellular components and toxins into the body is significantly increased by physical and psychological stress, drugs, surgery and irregularity (15-17).

The immune system plays a key role in protecting the host against hazardous foreign substances.  Moreover, a properly functioning immune system is also affected by a variety of exogenous environmental factors (infectious bacteria and viruses), drugs (immunosuppressants and immunostimulants), and intrinsic factors (genetics, stress, gastro intestinal disorders and aging associated with immunosenescence). In fact, lowered immune function may increase health risks such as susceptibility to disease causative pathogens.  Since immune function can be evaluated by determining the antibody response to foreign antigens, Chondrex provides a human anti-LPS IgG antibody ELISA kit as well as ELISAs  to measure IgA and IgG antibody levels to various types of pathogenic and non-pathogenic environmental factors (Table 1).  Please contact us for more information at support@chondrex.com.

This series of ELISA kits employ the ChonBlock® buffer system, which eliminates non-specific hydrophobic and ionic interactions in indirect ELISAs to provide accurate assay results. Chondrex also provides ChonBlock® buffer for in-house use for individual assay purposes. Please contact us for more information at support@chondrex.com.

Human Anti-LPS Antibody Assay Kit

Product Catalog # Price (USD)


Table 1. Human Antibody Assay kits


Human anti-LPS antibody assay kit
Lipopolysaccharide (LPS) is the dominant bacterial toxin in the intestinal tract and plays important roles in the development of the host’s immune system.  However, it is also highly likely that LPS plays important pathological roles in patients with chronic autoimmune diseases. 

 LPS is known to polyclonally active B-cells and consequently activate T-cells, but also triggers and exacerbates inflammatory reactions (5, 6), and may be involved in a pathogenic nature in various chronic diseases such as diabetes (14), systemic lupus erythematosus (10) and autoimmune hemolytic anemia (11).  Therefore, in order to understand the possible involvement of these environmental factors in the pathogenesis of autoimmune diseases, it is important to distinguish how healthy people and patients with diseases respond to these common bacterial toxins.

Pathogenic Environmental Factors and the Possible Contribution to Autoimmune Diseases
Various factors can disrupt the mucosal barrier function (a).  As a result, pathogenic intestinal 
bacterial components (mimic antigens) and their toxins can cross the mucosal barrier into 
the surrounding tissues and circulation, thus disrupting the immune homeostasis (b).


1.    Aoki S, Y.K., Yokoyama T, Nonogaki T, Iwasaki S, Mitsui T, Niwa S., Role of enteric bacteria in the
       pathogenesis of rheumatoid arthritis: evidence for antibodies to enterobacterial common antigens in
       rheumatoid sera and synovial fluids.
Ann Rheum Dis., 1996. 55: 363-9.

2.    Van der Heijden IM, W.B., Tchetverikov I, Schrijver IA, Schouls LM, Hazenberg MP, Breedveld FC, Tak PP.,
       Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis
       and other arthritides
. Arthritis Rheum., 2000. 43:593-8.

3.    Terato K, Y.X., Miyahara H, Cremer MA, Griffiths MM., Induction of chronic autoimmune arthritis in DBA/1
        mice by oral administration of type II collagen and E.coli LPS
. Br J Rheum, 1996. 35: 828-838.

4.    Peltonen R, N.M., Helve T, Hänninen O, Toivanen P, Eerola E. Faecal microbial flora and disease activity
       in rheumatoid arthritis during a vegan diet
. Br J Rheumatol, 1997. 36: 64-8.

5.    Toivanen, P., Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis. Ann Rheum
       Dis., 2003. 62: 807-11.

6.    Vaahtovuo J, M.E., Korkeamäki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid
. J Rheumatol., 2008. 35: 1500-5.

7.    Edwards, C., Commensal Gut Bacteria and the Etiopathogenesis of Rheumatoid Arthritis. J Rheum,
        2008. 35: 1477-78.

8.    Dayna Shi, J.D.a.G.D., Inflammatory bowel disease requires the interplay between innate and adaptive
       immune signals
. Cell Research, 2006. 16: 70–74.

9.    Nell S, S.S., Josenhans C, The impact of the microbiota on the pathogenesis of IBD: lessons from
       mouse infection models
. . Nat Rev Microbiol. 2010. 8: 564-77.

10.  Cavallo T, G.N., Bacterial lipopolysaccharide induces long-lasting IgA deficiency concurrently with
        features of polyclonal B cell activation in normal and in lupus-prone mice
. Clin Exp Immunol, 1991. 84:

11.  Murakami M, N.K., Yamazaki K, Muraguchi T, Serikawa T, Honjo T., Effects of breeding environments on
       generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice
. J
       Exp Med, 1997. 185: 791-4.

12.  Penhale WJ, Y.P., The influence of the normal microbial flora on the susceptibility of rats to experimental
       autoimmune thyroiditis
. Clin Exp Immunol, 1988. 72: 288-92.

13.  Murakami M, T.T., Shinkura R, Nisitani S, Okamoto M, Yoshioka H, Usui T, Miyawaki S, Honjo T., Oral
       administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of
       the gut and induces autoimmune symptoms in an autoantibody transgenic mouse
. J Exp Med, 1994.
       180: 111-21.

14.  Nymark M, P.P., Tuomainen AM, Forsblom C, Groop PH, Lehto M; FinnDiane Study Group., Serum
        lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with
        type 1 diabetes
. Diabetes Care, 2009. 32: 1689-93.

15.  Anderlik P, S.I., Bános Z, Barna Z., Bacterial translocation after cold stress in young and old mice. Acta
        Microbiol Hung, 1990. 37: 289-94.

16.  Velin AK, E.A., Braaf Y, Wallon C, Söderholm JD., Increased antigen and bacterial uptake in follicle
        associated epithelium induced by chronic psychological stress in rats
. Gut, 2004. 53: 494-500.

17. Khalif IL, Q.E., Konovitch EA, Maximova ID., Alterations in the colonic flora and intestinal permeability and
       evidence of immune activation in chronic constipation
. Dig Liver Dis, 2005. 37: 838-49.